Cited by 293Parkinson's Disease Mechanisms and TreatmentsNeurotransmitter Receptor Influence on BehaviorNeural and Behavioral Psychology Studies

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Dopamine Modulates the Response of the Human Amygdala: A Study in Parkinson's Disease

Open access

Tessitore, Alessandro, Hariri, Ahmad R., Fera, Francesco, Smith, William G., Chase, Thomas N., Hyde, Thomas M., Weinberger, Daniel R., Mattay, Venkata S.·2002·The Journal of Neuroscience

DOI 10.1523/jneurosci.22-20-09099.2002PMC PMC6757686

Open this paper in CoChat — free account Open PDF

Abstract

In addition to classic motor signs and symptoms, Parkinson's disease (PD) is characterized by neuropsychological and emotional deficits, including a blunted emotional response. In the present study, we explored both the neural basis of abnormal emotional behavior in PD and the physiological effects of dopaminergic therapy on the response of the amygdala, a central structure in emotion processing. PD patients and matched normal controls (NCs) were studied with blood oxygenation level-dependent functional magnetic resonance imaging during a paradigm that involved perceptual processing of fearful stimuli. PD patients were studied twice, once during a relatively hypodopaminergic state (i.e., > or =12 hr after their last dose of dopamimetic treatment) and again during a dopamine-replete state. The imaging data revealed a robust bilateral amygdala response in NCs that was absent in PD patients during the hypodopaminergic state. Dopamine repletion partially restored this response in PD patients. Our results demonstrate an abnormal amygdala response in PD that may underlie the emotional deficits accompanying the disease. Furthermore, consistent with findings in experimental animal paradigms, our results provide in vivo evidence of the role of dopamine in modulating the response of the amygdala to sensory information in human subjects.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1523/jneurosci.22-20-09099.2002

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
Overdependence on degraded gist memory in Alzheimer's disease.
Gallo, D. A., Shahid, K. R., Olson, M. A., Solomon, T. M., Schacter, D. L., & Budson, A. E. (2006) · Neuropsychology · doi:10.1037/0894-4105.20.6.625 · Cited by 4,757
Pictures of Facial Affect
Ekman, P. (1976) · Medical Entomology and Zoology · Cited by 4,345
Untitled work
(1996) · Cited by 3,692
Unified Parkinson's Disease Rating Scale
(2012) · Springer eBooks · doi:10.1007/springerreference_184495 · Cited by 3,071
The amygdala: vigilance and emotion
Davis, M., & Whalen, P. J. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000812 · Cited by 2,882
Parkinsonism: Onset, progression, and mortality
Hoehn, M., & Yahr, M. (2011) · Neurology · doi:10.1212/01.wnl.0000405146.06300.91 · Cited by 1,888
The functional neuroanatomy of emotion and affective style
Davidson, R. J., & Irwin, W. (1999) · Trends in Cognitive Sciences · doi:10.1016/s1364-6613(98)01265-0 · Cited by 1,684
Neuropathology of Parkinson's Disease
Forno, L. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199603000-00001 · Cited by 1,556
A neuromodulatory role for the human amygdala in processing emotional facial expressions
Morris, J. (1998) · Brain · doi:10.1093/brain/121.1.47 · Cited by 1,291

Show all 47 references

Research works printed but not linked: 1

Hariri AR, Mattay VS, Tessitore A, Fera F, Smith WG, Weinberger DR (2002) Dextroamphetamine potentiates the human amygdala response to fearful stimuli. Neuropsychopharmacology, in press.

Sorted by citations

Items 101–200 of 293

Reduced early visual emotion discrimination as an index of diminished emotion processing in Parkinson’s disease? – Evidence from event-related brain potentials
Wieser, M. J., Klupp, E., Weyers, P., Pauli, P., Weise, D., Zeller, D., Claßen, J., & Mühlberger, A. (2011) · Cortex · doi:10.1016/j.cortex.2011.06.006 · Cited by 51
Impulse control disorders in Parkinson’ disease: the role of personality and cognitive status
Poletti, M., & Bonuccelli, U. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6506-6 · Cited by 51
Facial Emotion Recognition in Parkinson's Disease: An fMRI Investigation
Wabnegger, A., Ille, R., Schwingenschuh, P., Katschnig, P., Kögl-Wallner, M., Wenzel, K., & Schienle, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136110 · Cited by 50
Startle reflex hyporeactivity in Parkinson's disease: An emotion-specific or arousal-modulated deficit?
Miller, K. M., Okun, M. S., Marsiske, M., Fennell, E. B., & Bowers, D. (2009) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2009.03.002 · Cited by 52
Voluntary Physical Exercise Improves Subsequent Motor and Cognitive Impairments in a Rat Model of Parkinson’s Disease
Hsueh, S., Chen, K., Lai, J.-H., Wu, C.-C., Yu, Y.-W., Luo, Y., Hsieh, T.-H., & Chiang, Y. H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020508 · Cited by 49
Oscillatory subthalamic nucleus activity is modulated by dopamine during emotional processing in Parkinson's disease
Huebl, J., Spitzer, B., Brücke, C., Schönecker, T., Kupsch, A. R., Alesch, F., Schneider, G., & Kühn, A. A. (2014) · Cortex · doi:10.1016/j.cortex.2014.02.019 · Cited by 51
Decreased voluntary activity and amygdala levels of serotonin and dopamine in ovariectomized rats
Izumo, N., Ishibashi, Y., Ohba, M., Morikawa, T., & Manabe, T. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.10.031 · Cited by 48
Balance problems with Parkinson's disease: are they anxiety-dependent?
Pasman, E. P., Murnaghan, C. D., Bloem, B. R., & Carpenter, M. G. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2010.12.050 · Cited by 47
Imaging oxytocin × dopamine interactions: an epistasis effect of CD38 and COMT gene variants influences the impact of oxytocin on amygdala activation to social stimuli
Sauer, C., Montag, C., Reuter, M., & Kirsch, P. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00045 · Cited by 49
Emotion classification in Parkinson's disease by higher-order spectra and power spectrum features using EEG signals: A comparative study
Yuvaraj, R., Murugappan, M., Ibrahim, N. M., Omar, M. I., Sundaraj, K., Mohamad, K., Palaniappan, R., & Satiyan, M. (2014) · Journal of Integrative Neuroscience · doi:10.1142/s021963521450006x · Cited by 46
Modeling Neurodegenerative Diseases in vivo Review
Halbach, O. V. B. U. (2005) · Neurodegenerative Diseases · doi:10.1159/000092318 · Cited by 47
The amygdala: inside and out
Hariri, A. R., & Whalen, P. J. (2011) · F1000 Biology Reports · doi:10.3410/b3-2 · Cited by 51
Self-citation
Neuropsychological correlates of alexithymia in Parkinson's disease
da Costa, A. L. C., Peppe, A., Carlesimo, G. A., Salamone, G., & Caltagirone, C. (2007) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617707071329 · Cited by 46
Dopamine and the Development of Executive Dysfunction in Autism Spectrum Disorders
Kriete, T. E., & Noelle, D. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121605 · Cited by 49
The Role of Dopamine in Attentional and Memory Biases for Emotional Information
Gibbs, A. A., Naudts, K. H., Spencer, E. P., & David, A. S. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06081241 · Cited by 47
Imaging genetics and the neurobiological basis of individual differences in vulnerability to addiction
Sweitzer, M. M., Donny, E. C., & Hariri, A. R. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.01.017 · Cited by 46
Self-citation
Behavioural manifestations and associated non-motor features of freezing of gait: A narrative review and theoretical framework
Martens, K. A. E., Peterson, D. S., Almeida, Q. J., Lewis, S. J. G., Hausdorff, J. M., & Nieuwboer, A. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.06.026 · Cited by 47
Dopaminergic Modulation of Amygdala Activity During Emotion Recognition in Patients With Parkinson Disease
Delaveau, P., Salgado‐Pineda, P., Witjas, T., Micallef, J., Fakra, É., Azulay, J., & Blin, O. J. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181bf1c5f · Cited by 44
Contribution of Dopamine D1 and D2 Receptors to Amygdala Activity in Human
Takahashi, H., Takano, H., Kodaka, F., Arakawa, R., Yamada, M., Otsuka, T., Hirano, Y., Kikyo, H., Okubo, Y., Kato, M., et al. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5689-09.2010 · Cited by 42
Neurodegeneration and the Cerebellum
Samson, M., & Claassen, D. O. (2017) · Neurodegenerative Diseases · doi:10.1159/000460818 · Cited by 42
Role of habenula and amygdala dysfunction in Parkinson disease patients with punding
Marković, V., Agosta, F., Canu, E., Inuggi, A., Petrović, I. N., Stanković, I., Imperiale, F., Stojković, T., Kostić, V., & Filippi, M. (2017) · Neurology · doi:10.1212/wnl.0000000000004012 · Cited by 42
Failing as doorman and disc jockey at the same time: Amygdalar dysfunction in Parkinson's disease
Diederich, N. J., Goldman, J. G., Stebbins, G. T., & Goetz, C. G. (2015) · Movement Disorders · doi:10.1002/mds.26460 · Cited by 41
Effect of Levodopa on Healthy Volunteers' Facial Emotion Perception
Delaveau, P., Salgado‐Pineda, P., Wicker, B., Micallef, J., & Blin, O. J. (2005) · Clinical Neuropharmacology · doi:10.1097/01.wnf.0000186651.96351.2e · Cited by 40
The late positive potential, emotion and apathy in Parkinson’s disease
Dietz, J., Bradley, M. M., Jones, J. D., Okun, M. S., Perlstein, W. M., & Bowers, D. (2013) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2013.01.001 · Cited by 37
Stress-evoking emotional stimuli exaggerate deficits in motor function in Parkinson's disease
Blakemore, R. L., MacAskill, M. R., Shoorangiz, R., & Anderson, T. (2018) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2018.03.006 · Cited by 37
[18F]fallypride characterization of striatal and extrastriatal D2/3 receptors in Parkinson's disease
Stark, A. J., Smith, C. T., Petersen, K. J., Trujillo, P., van Wouwe, N. C., Donahue, M. J., KESSLER, R. M., Deutch, A. Y., Zald, D. H., & Claassen, D. O. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.02.010 · Cited by 37
Virtually-induced threat in Parkinson's: Dopaminergic interactions between anxiety and sensory–perceptual processing while walking
Martens, K. A. E., Ellard, C. G., & Almeida, Q. J. (2015) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2015.05.015 · Cited by 36
Dopamine agonists in the treatment of non‐motor symptoms of Parkinson’s disease: depression
Lemke, M. R. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02213.x · Cited by 36
Emotion recognition in early Parkinson’s disease patients undergoing deep brain stimulation or dopaminergic therapy: a comparison to healthy participants
McIntosh, L. G., Mannava, S., Camalier, C. R., Folley, B. S., Albritton, A., Konrad, P. E., Charles, D. P., Park, S., & Neimat, J. S. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00349 · Cited by 35
An fMRI study into emotional processing in Parkinson’s disease: Does increased medial prefrontal activation compensate for striatal dysfunction?
Moonen, A. J. H., Weiss, P. H., Wiesing, M., Weidner, R., Fink, G. R., Reijnders, J. S. A. M., Weber, W. E. J., & Leentjens, A. F. G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177085 · Cited by 39
Impact of gender and genetics on emotion processing in Parkinson's disease - A multimodal study
Heller, J., Mirzazade, S., Romanzetti, S., Habel, U., Derntl, B., Freitag, N. M., Schulz, J. B., Dogan, I., & Reetz, K. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.01.034 · Cited by 37
Functional MRI in Parkinson's Disease Cognitive Impairment
Baggio, H. C., & Junqué, C. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.09.010 · Cited by 34
Abnormal Emotional Word Ratings in Parkinson's Disease
Hillier, A. J., Beversdorf, D. Q., Raymer, A. M., Williamson, D. J. G., & Heilman, K. M. (2007) · Neurocase · doi:10.1080/13554790701300500 · Cited by 33
Emotion recognition in Parkinson's disease after subthalamic deep brain stimulation: Differential effects of microlesion and STN stimulation
Aiello, M., Eleopra, R., Lettieri, C., Mondani, M., D’Auria, S., Belgrado, E., Piani, A., Simone, L. D., Rinaldo, S., & Rumiati, R. I. (2013) · Cortex · doi:10.1016/j.cortex.2013.11.003 · Cited by 37
Emotion and ocular responses in Parkinson's disease
Dietz, J., Bradley, M. M., Okun, M. S., & Bowers, D. (2011) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2011.07.029 · Cited by 32
Emotional dysfunctions in neurodegenerative diseases
Loeffler, L. A. K., Radke, S., Morawetz, C., & Derntl, B. (2015) · The Journal of Comparative Neurology · doi:10.1002/cne.23816 · Cited by 32
Genetic differences in emotionally enhanced memory
Todd, R. M., Palombo, D. J., Levine, B., & Anderson, A. K. (2010) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2010.11.010 · Cited by 34
Laughter Yoga, Adults Living With Parkinson׳s Disease, and Caregivers: A Pilot Study.
DeCaro, D., & Brown, J. L. C. (2016) · Explore · doi:10.1016/j.explore.2016.02.005 · Cited by 33
Pre-encoding administration of amphetamine or THC preferentially modulates emotional memory in humans
Ballard, M. E., Gallo, D. A., & de Wit, H. (2013) · Psychopharmacology · doi:10.1007/s00213-012-2924-5 · Cited by 32
Schizophrenia and Parkinson’s disease: Selected therapeutic advances beyond the dopaminergic etiologies
Ghanemi, A. (2013) · Alexandria Journal of Medicine · doi:10.1016/j.ajme.2013.03.005 · Cited by 31
Limbic grey matter changes in early Parkinson's disease
Li, X., Xing, Y., Schwarz, S. T., & Auer, D. P. (2017) · Human Brain Mapping · doi:10.1002/hbm.23610 · Cited by 32
Impaired decision-making in idiopathic REM sleep behavior disorder
Sasai, T., Miyamoto, T., Miyamoto, M., Iwanami, M., Abe, T., Matsuura, M., & Inoue, Y. (2012) · Sleep Medicine · doi:10.1016/j.sleep.2011.09.012 · Cited by 30
Integrating biological treatment mechanisms into randomized clinical trials: Design of PROGrESS (PROlonGed ExpoSure and Sertraline Trial)
Rauch, S. A. M., Simon, N. M., Kim, H. M., Acierno, R. E., King, A. P. J., Norman, S. B., Venners, M. R., Porter, K. E., Phan, K. L., Tuerk, P. W., et al. (2017) · Contemporary Clinical Trials · doi:10.1016/j.cct.2017.10.013 · Cited by 30
Dopamine D1 Binding Potential Predicts Fusiform BOLD Activity during Face-Recognition Performance
Bart Rypma, A., Fischer, H., Rieckmann, A., Hubbard, N. A., Nyberg, L. H., & Bäckman, L. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.1298-15.2015 · Cited by 30
Impaired Emotional Mirroring in Parkinson’s Disease—A Study on Brain Activation during Processing of Facial Expressions
Pohl, A., Anders, S., Chen, H., Patel, H., Heller, J., Reetz, K., Mathiak, K., & Binkofski, F. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00682 · Cited by 29
Investigation of serotonergic Parkinson's disease-related covariance pattern using [11C]-DASB/PET
Fu, J. F., Klyuzhin, I. S., Liu, S., Shahinfard, E., Vafai, N. M., McKenzie, J., Neilson, N., Mabrouk, R., Sacheli, M., Wile, D. J., et al. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.05.022 · Cited by 29
Oxytocin selectively modulates brain processing of disgust in Huntington's disease gene carriers
Labuschagne, I., Poudel, G. R., Kordsachia, C. C., Wu, Q., Thomson, H. M., Georgiou‐Karistianis, N., & Stout, J. C. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.09.023 · Cited by 30
Increased dopamine release in vivo by estradiol benzoate from the central amygdaloid nucleus of Parkinson's disease model rats
Liu, B., & Xie, J. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02518.x · Cited by 28
COMT Met (158) modulates facial emotion recognition in bipolar I disorder mood episodes
Soeiro‐de‐Souza, M. G., Bio, D. S., David, D. P., dos Santos, D. R., Kerr, D. S., Gattaz, W. F., Machado‐Vieira, R., & Moreno, R. A. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.11.021 · Cited by 29
Inter-hemispheric EEG coherence analysis in Parkinson’s disease: Assessing brain activity during emotion processing
Yuvaraj, R., Murugappan, M., Ibrahim, N. M., Sundaraj, K., Omar, M. I., Mohamad, K., Palaniappan, R., & Satiyan, M. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1249-4 · Cited by 27
Type 2 Diabetes Mellitus Is Associated with Social Recognition Memory Deficit and Altered Dopaminergic Neurotransmission in the Amygdala
Parashar, A., Mehta, V., & Malairaman, U. (2017) · Annals of Neurosciences · doi:10.1159/000479637 · Cited by 28
Impact of dopamine and cognitive impairment on neural reactivity to facial emotion in Parkinson's disease
Dan, R., Růžička, F., Bezdíček, O., Roth, J., Růžička, E., Vymazal, J., Goelman, G., & Jech, R. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.09.003 · Cited by 27
Adaptation and well-being : social allostasis
Schulkin, J. A. (2011) · Cited by 26
Alteraciones emocionales en el trastorno por déficit de atención/hiperactividad: datos existentes y cuestiones abiertas
Bitaubé, J. A., López‐Martín, S., Fernández‐Jaén, A., & Arangüena, L. C. (2008) · Revista de Neurología · doi:10.33588/rn.4701.2008111 · Cited by 30
Association between amygdala reactivity and a dopamine transporter gene polymorphism
Bergman, O., Åhs, F., Furmark, T., Appel, L., Linnman, C., Faria, V., Bani, M., Pich, E. M., Bettica, P. U., Henningsson, S., et al. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.50 · Cited by 26
Self-citation
Amygdala Activation Modulated by Levodopa During Emotional Recognition Processing in Healthy Volunteers
Delaveau, P., Salgado‐Pineda, P., Micallef, J., & Blin, O. J. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31815a444d · Cited by 26
Sensory focused exercise improves anxiety in Parkinson’s disease: A randomized controlled trial
Beck, E. N., Wang, M. T. Y., Intzandt, B., Almeida, Q. J., & Martens, K. A. E. (2020) · PLoS ONE · doi:10.1371/journal.pone.0230803 · Cited by 25
The Feasibility and Positive Effects of Wuqinxi Exercise on the Cognitive and Motor Functions of Patients with Parkinson’s Disease: A Pilot Study
Shen, M., Pi, Y., Li, Z., Song, T., Jie, K., Wang, T., Guo, W., Zhuang, J., & Wang, Z. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/8833736 · Cited by 24
Subjective emotional experience at different stages of Parkinson's disease
Vicente, S., Péron, J., Biseul, I., Ory, S., Philippot, P., Drapier, S., Drapier, D., & Vérin, M. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.06.033 · Cited by 25
Activation and blockade of basolateral amygdala 5-HT6 receptor produce anxiolytic-like behaviors in an experimental model of Parkinson’s disease
Sun, Y., Yao, L., Li, L., Wang, Y., Du, C., Guo, Y., & Liu, J. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.05.016 · Cited by 24
Neurobiological correlates of emotional processing in Parkinson's disease: A systematic review of experimental studies
Moonen, A. J. H., Wijers, A. A., Dujardin, K., & Leentjens, A. F. G. (2017) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2017.07.009 · Cited by 23
Humor as a Reward Mechanism: Event-Related Potentials in the Healthy and Diseased Brain
Mensen, A., Poryazova, R., Schwartz, S., & Khatami, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085978 · Cited by 27
A general clinical overview of the non-motor symptoms in Parkinson’s disease: Neuropsychiatric symptoms
Batzu, L., Podlewska, A. M., Gibson, L. L., Chaudhuri, К. R., & Aarsland, D. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2023.11.001 · Cited by 25
Emotion processing in Parkinson's disease: an EEG spectral power study
Yuvaraj, R., Murugappan, M., Omar, M. I., Ibrahim, N. M., Sundaraj, K., Mohamad, K., & Satiyan, M. (2013) · International Journal of Neuroscience · doi:10.3109/00207454.2013.860527 · Cited by 21
Action and emotion perception in Parkinson’s disease: A neuroimaging meta-analysis
Arioli, M., Cattaneo, Z., Rusconi, M. L., Blandini, F., & Tettamanti, M. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.103031 · Cited by 22
Discriminating facial expressions of emotion and its link with perceiving visual form in Parkinson's disease
Marneweck, M., & Hammond, G. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.08.014 · Cited by 21
Human dopamine receptor D2/D3 availability predicts amygdala reactivity to unpleasant stimuli
Kobiella, A., Vollstädt‐Klein, S., Fauth‐Bühler, M., Graf, C., Buchholz, H., Bernow, N., Yakushev, I. Y., Landvogt, C., Schreckenberger, M., Gründer, G., et al. (2009) · Human Brain Mapping · doi:10.1002/hbm.20900 · Cited by 21
Antidepressant-Like Properties of Intrastriatal Botulinum Neurotoxin-A Injection in a Unilateral 6-OHDA Rat Model of Parkinson’s Disease
Antipova, V., Holzmann, C., Hawlitschka, A., Witt, M., & Wree, A. (2021) · Toxins · doi:10.3390/toxins13070505 · Cited by 20
Dopamine-related dissociation of cortical and subcortical brain activations in cognitively unimpaired Parkinson’s disease patients OFF and ON medications
Kim, J., Zhang, K., Cai, W., YorkWilliams, S. L., Cruadhlaoich, M. A. I. U., Llanes, S. J., Menon, V., & Poston, K. L. (2018) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2018.07.024 · Cited by 20
The dopamine D4/D2 receptor antagonist affinity ratio as a predictor of anti-aggression medication efficacy
El‐Mallakh, R. S., & McKenzie, C. E. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2012.10.014 · Cited by 22
Age-dependent effects of acute methylphenidate on amygdala reactivity in stimulant treatment-naive patients with attention deficit/hyperactivity disorder
Bottelier, M. A., Schrantee, A., Ferguson, B., Tamminga, H. G. H., Bouziane, C., Kooij, J. J. S., de Ruiter, M. B., & Reneman, L. (2017) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2017.09.009 · Cited by 19
Effects of dopaminergic modulation on electrophysiological brain response to affective stimuli
Franken, I. H. A., Nijs, I. M. T., & Pepplinkhuizen, L. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0941-6 · Cited by 19
Emotional processing in Parkinson's disease
Troisi, E., Peppe, A., Pierantozzi, M., Matteis, M., Vernieri, F., Stanzione, P., Silvestrini, M., & Caltagirone, C. (2002) · Journal of Neurology · doi:10.1007/s00415-002-0769-2 · Cited by 18
The Neurotransmission Basis of Post-Traumatic Stress Disorders by the Fear Conditioning Paradigm
Traina, G., & Tuszyński, J. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216327 · Cited by 19
The Catechol-O-Methyltransferase and Dopamine Transporter Genes Moderated the Impact of Peer Relationships on Adolescent Depressive Symptoms: A Gene–Gene–Environment Study
Cao, Y., Lin, X., Chen, L., Ji, L., & Zhang, W. (2018) · Journal of Youth and Adolescence · doi:10.1007/s10964-018-0925-3 · Cited by 18
Mesocorticolimbic dopamine functioning in primary psychopathy: A source of within-group heterogeneity
Yildirim, B. O., & Derksen, J. J. L. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.07.005 · Cited by 20
Serotonergic neurons mediate the anxiolytic effect of l-DOPA: Neuronal correlates in the amygdala
Faggiani, E., Naudet, F., Janssen, M. L. F., Temel, Y., & Benazzouz, A. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.11.001 · Cited by 18
Specialization of amygdala subregions in emotion processing
Labuschagne, I., Domínguez, J. F., Grace, S., Mizzi, S., Henry, J. D., Peters, C. A., Rabinak, C. A., Sinclair, E., Lorenzetti, V., Terrett, G., et al. (2024) · Human Brain Mapping · doi:10.1002/hbm.26673 · Cited by 21
Implicit and explicit emotional processing in Parkinson's disease
Borg, C., Bedoin, N., Bogey, S., Michael, G. A., Poujois, A., Laurent, B., & Thomas-Antérion, C. (2012) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2011.639296 · Cited by 19
Neural correlates of emotional valence processing in Parkinson’s disease: dysfunction in the subcortex
Bell, P. T., Gilat, M., Shine, J. M., McMahon, K. L., Lewis, S. J. G., & Copland, D. A. (2017) · Brain Imaging and Behavior · doi:10.1007/s11682-017-9754-3 · Cited by 17
The neuropathological basis of anxiety in Parkinson’s disease
Overton, P. G., & Coizet, V. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110048 · Cited by 17
Anxiety in Parkinson’s Disease: A Systematic Review of Neuroimaging Studies
Perepezko, K. M., Naaz, F., Wagandt, C., Dissanayaka, N. N., Mari, Z. K., Nanavati, J., Bakker, A., & Pontone, G. M. (2021) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.20110272 · Cited by 17
Differential role of dopamine in emotional attention and memory: Evidence from Parkinson's disease
Hälbig, T. D., Assuras, S., Creighton, J., Borod, J. C., Tse, W., Frisina, P. G., Voustianiouk, A., Graciès, J., & Olanow, C. W. (2011) · Movement Disorders · doi:10.1002/mds.23728 · Cited by 17
Different effects of levodopa and subthalamic stimulation on emotional conflict in Parkinson's disease
Martínez‐Fernández, R., Kibleur, A., Chabardès, S., Fraix, V., Castrioto, A., Lhommée, E., Moro, E., Lescoules, L., Pélissier, P., Olivier David, A., et al. (2018) · Human Brain Mapping · doi:10.1002/hbm.24341 · Cited by 15
Improvement of non-motor and motor behavioral alterations associated with Parkinson-like disease in Drosophila melanogaster: Comparative effects of treatments with hesperidin and L-dopa
Poetini, M. R., Musachio, E. A. S., Araújo, S. M., Bortolotto, V. C., Meichtry, L. B., Silva, N. C., Janner, D. E., Novo, D. L. R., Mesko, M. F., Roehrs, R., et al. (2022) · NeuroToxicology · doi:10.1016/j.neuro.2022.02.004 · Cited by 16
MPTP Treatment Impairs Tyrosine Hydroxylase Immunopositive Fibers Not Only in the Striatum, but Also in the Amygdala
Halbach, O. V. B. U., Schober, A., Hertel, R., & Unsicker, K. (2005) · Neurodegenerative Diseases · doi:10.1159/000086430 · Cited by 18
A subcortical network for implicit visuo-spatial attention: Implications for Parkinson's Disease
Esposito, M., Tamietto, M., Geminiani, G. C., & Celeghin, A. (2021) · Cortex · doi:10.1016/j.cortex.2021.05.003 · Cited by 16
Tumor suppression and improvement in immune systems by specific activation of dopamine D1-receptor-expressing neurons in the nucleus accumbens
Sato, D., Hamada, Y., Narita, M., Mori, T., Tezuka, H., Suda, Y., Tanaka, K., Yoshida, S., Tamura, H., Yamanaka, A., et al. (2022) · Molecular Brain · doi:10.1186/s13041-022-00902-1 · Cited by 15
Experience of negative emotions in Parkinson’s disease: An fMRI investigation
Schienle, A., Ille, R., & Wabnegger, A. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.10.046 · Cited by 15
The Effect of Lateralization of Motor Onset and Emotional Recognition in PD Patients Using EEG
Yuvaraj, R., Murugappan, M., & Palaniappan, R. (2016) · Brain Topography · doi:10.1007/s10548-016-0524-0 · Cited by 15
Neuroimaging and facial affect processing: implications for traumatic brain injury
Neumann, D. M., Keiski, M. A., McDonald, B. C., & Wang, Y. (2013) · Brain Imaging and Behavior · doi:10.1007/s11682-013-9285-5 · Cited by 15
Dopaminergic modulation of memory and affective processing in Parkinson depression
Blonder, L. X., Slevin, J. T., Kryscio, R. J., Martin, C. A., Andersen, A. H., Smith, C. D., & Schmitt, F. A. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.06.003 · Cited by 15
Interaction between DRD2 variation and sound environment on mood and emotion-related brain activity
Quarto, T., Fasano, M. C., Taurisano, P., Fazio, L., Antonucci, L. A., Gelao, B., Romano, R., Mancini, M., Porcelli, A., Masellis, R., et al. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.11.010 · Cited by 18
Effects of Subthalamic Nucleus Deep Brain Stimulation on Facial Emotion Recognition in Parkinson’s Disease: A Critical Literature Review
Kalampokini, S., Lyros, E., Lochner, P., Fassbender, K. C., & Unger, M. M. (2020) · Behavioural Neurology · doi:10.1155/2020/4329297 · Cited by 15
Section II. The Dopamine System
Smythies, J. (2005) · International review of neurobiology · doi:10.1016/s0074-7742(05)64002-0 · Cited by 15
Intracerebral microinjection of stannous 2‐ethylhexanoate affects dopamine turnover in cerebral cortex and locomotor activity in rats
Yamada, T., Jung, D., Sawada, R., & Tsuchiya, T. (2008) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.31115 · Cited by 15
Influence of COMT val158met and ADRA2B deletion polymorphisms on recollection and familiarity components of human emotional memory
Naudts, K. H., Azevedo, R. T., David, A. S., Heeringen, C. V., & Gibbs, A. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111416688 · Cited by 15
Troubles de la reconnaissance des expressions faciales émotionnelles dans la maladie de Parkinson
Lachenal-Chevallet, K., Bediou, B., Bouvard, M. A., Thobois, S., Broussolle, E., Vighetto, A., & Krolak‐Salmon, P. (2006) · Archive ouverte UNIGE (University of Geneva) · Cited by 14
Gray matter structural and functional brain abnormalities in Parkinson’s disease: a meta-analysis of VBM and ALFF data
Wang, L., Xiong, X., Liu, J., Liu, R., Liao, J., Fan, L., Lu, S., Wang, W., Zhuo, L., & Li, H. (2025) · Journal of Neurology · doi:10.1007/s00415-025-12934-3 · Cited by 12
Closed-Loop VR-Based Interaction to Improve Walking in Parkinson’s Disease
Chong, R. K. Y., Lee, K. H., Morgan, J. C., & Mehta, S. H. (2011) · Journal of Novel Physiotherapies · doi:10.4172/2165-7025.1000101 · Cited by 12

Authors: Tessitore, A., Hariri, A. R., Fera, F., Smith, W. G., Chase, T. N., Hyde, T. M., Weinberger, D. R., & Mattay, V. S.
Affiliations: National Institute of Mental Health (US)
National Institutes of Health (US)
ORCID: Tessitore, Alessandro
Hariri, Ahmad R.
Hyde, Thomas M.
Weinberger, Daniel R.
Mattay, Venkata S.
Venue: The Journal of Neuroscience
Publisher: Society for Neuroscience
Published: 2002-10-15
Volume: 22
Issue: 20
Pages: 9099-9103
ISSN: 0270-6474 (ISSN-L)
1529-2401
DOI: 10.1523/jneurosci.22-20-09099.2002
PMC: PMC6757686
OpenAlex: W2158459330
Cited by: 293
References: 47
Citations by year: 2026: 5 · 2025: 6 · 2024: 6 · 2023: 3 · 2022: 4 · 2021: 13 · 2020: 6 · 2019: 9 · 2018: 16 · 2017: 15 · 2016: 15 · 2015: 18 · 2014: 18 · 2013: 13 · 2012: 15
FWCI: 5.97
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Neuroscience (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
Keywords: Parkinson's disease, dopamine, amygdala, emotional deficits, fear processing, dopaminergic therapy, hypodopaminergic state, emotional processing, functional MRI
MeSH terms: Amygdala, Antiparkinson Agents, Behavior, Brain Mapping, Dopamine, Drug Therapy, Combination, Emotions, Facial Expression, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Parkinson Disease, Pattern Recognition, Visual, Photic Stimulation, Reaction Time, Reference Values, Dopamine Agonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Dopamine Modulates the Response of the Human Amygdala: A Study in Parkinson's Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks